TENSOR BIO
Dead / Abandoned — Abandoned — no statement of use filed (as of 02 Jan 2023)
What this means for you
This application is over — abandoned 02 Jan 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 90237666
- Mark type
- Stylized text
- Filed
- 06 Oct 2020
- Published for opposition
- 05 Apr 2022
- Abandoned
- 02 Jan 2023
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 001 — Chemicals: medical test kits to aid in the diagnosis of disease, namely, kits primarily containing clinical medical reagents for use in disease testing for clinical medical laboratory use
- Class 005 — Pharmaceuticals: medical tests kits primarily comprised of medical diagnostic reagents for performing liquid biopsy
- Class 010 — Medical apparatus: diagnostic apparatus using machine learning for the detection of diseases using liquid biopsy, excluding measuring physiological parameters in the nature of blood pressure, heartbeat and pulse
- Class 044 — Medical, beauty and agricultural services: medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring, and reporting services
Owner
- Tensor Biosciences, Inc., Palo Alto, CA, US
- Tensor Biosciences, Inc., Palo Alto, CA, US
Prosecution history
- 03 Jan 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 02 Jan 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 31 May 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 05 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 05 Apr 2022 — PUBLISHED FOR OPPOSITION
- 16 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Mar 2022 — EXAMINER'S AMENDMENT ENTERED
- 01 Mar 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 01 Mar 2022 — EXAMINERS AMENDMENT E-MAILED
- 01 Mar 2022 — EXAMINERS AMENDMENT -WRITTEN
- 28 Feb 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 28 Feb 2022 — NON-FINAL ACTION E-MAILED
- 28 Feb 2022 — NON-FINAL ACTION WRITTEN
- 08 Feb 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED